This observations suggests that lower dose of ATO is inducing a phase delay of the Per1 and Per3 gene expression, as well as for Cry1. However, this effect was not observed in the cultures derived from ADHD participants. This evidence concerns the gene CRY1 and attention deficit-hyperactivity disorder.